Skip to content Skip to global navigation Skip to main navigation Skip to sub navigation Skip to search
NHMRC

NHMRC supports World AIDS Day

Summary media release information

Date: 
30 November 2012
Type: 
NHMRC Media Release
Contact for further information: 
NHMRC Media Team: David Cooper, 0422 008 512

Thirty years since the HIV pandemic was recognised as one of the greatest international health threats in the modern era, World AIDS Day is an opportunity to raise awareness and encourage progress in HIV / AIDS prevention, treatment and care around the world.

“While antiretroviral therapies have been developed to slow the progression of HIV, there remains no cure or vaccine. NHMRC’s funding supports research that will boost our knowledge of HIV and take us closer to a future where the health impact of HIV can be eliminated,” NHMRC CEO, Professor Warwick Anderson said.

Since 2000, NHMRC has funded $100 million for HIV research. This year, NHMRC funded an additional 23 grants worth $13 million. This funding comes at a time when recent research on HIV shows that new infections rose over 8% in 2011.

Commenting on the newly funded NHMRC grants, Burnet Institute Deputy-Director Associate Professor David Anderson said “much progress has been made after 30 years of intense research but we must not become complacent. Globally 34 million people are living with HIV – with about half of them unaware of their HIV status.”

Monash University Provost and Senior Vice-President, Professor Edwina Cornish added “World AIDS Day is a reminder of the progress we have made and the work still to be done in bringing an end to this disease.”

NHMRC funding for HIV research

Highlights from NHMRC’s October grants announcement:

  • Associate Professor Anthony Jaworowski, Macfarlane Burnet Institute for Medical Research and Public Health will receive $598,939 to investigate the relationship between persistent abnormalities in natural killer cells in HIV patients and early death from non-AIDS cancers.
  • Dr Paul Cameron, Monash University will receive $489,927 to explore how the factors controlling T cells affect virus expression and therefore potentially identify new ways to eliminate HIV infection.

Further information